Introduction
Primitive neuroectodermal tumors (PNETs) are small round-cell tumors that often show neuroectodermal differentiation. They can be either central or peripheral. Central PNETs are derived from the neural tube predominantly involving the brain or spinal cord. Peripheral PNETs (pPNETs) are derived from the neural crest involving the sympathetic nervous system, bone, or soft tissue [1] . The most common site of pPNET in the female genital tract is the ovary, reported in 27 cases [2] [3] [4] . The uterus is the next most common site, with 14 cases reported to date [5] . Cervical, vaginal, and vulvar pPNET are rare, with seven, four, and three cases reported at each primary site, respectively [5] [6] [7] [8] [9] [10] [11] [12] [13] . To the best of our knowledge, we report the first case of uterine neuroectodermal tumor in Taiwan. We also review the literature on this topic.
Case Report
A 52-year-old perimenopausal woman, gravida 5, para 3 (all term vaginal deliveries), spontaneous abortus 2, had had a left ovarian tiny cyst and multiple small myoma uteri since 1997. She received regular follow-up examinations at our clinic without remarkable symptoms or signs. At one examination for Pap smear on August 29, 2003, two adnexal masses (6.6 3.2 cm and 5. Pelvic examination revealed an enlarged uterus, approximately the size of a fist, with severe tenderness. Transvaginal ultrasound showed an ill-defined and heterocomplex pelvic mass measuring 10.7 6.8 cm on the anterior uterine wall and multiple uterine myomas (3.9 3.9 cm, 4.6 3.9 cm, 3.9 3.4 cm, 1.5 1.0 cm). Pelvic computed tomography (CT) with contrast medium disclosed a huge heterogeneous tumor with an irregular shape arising from the anterior wall of the uterus (Figure 1 ).
The impression of malignant pelvic tumor and multiple myoma led to exploratory laparotomy. After opening the peritoneum, 20 mL of yellowish ascites was found. A major friable and necrotic tumor measuring 11 13 6 cm arose from the anterior uterine wall and extended to the bladder (Figure 2 ). The vesicouterine fold was severely adhesive so that there would be bladder injury or even cystectomy if we performed a hysterectomy. Bilateral ovaries and tubes were atrophied and unremarkable. Multiple myoma uteri were also noted. Another two major polypoid tumors were located on the right posterior surface of the broad ligament and left uterosacral ligament (3 3 cm and 2 3 cm, respectively). There were many small tumors on the posterior wall of the uterus extending inferiorly to the vagina. Partial tumor resection with postoperative chemotherapy and radiation without hysterectomy and cystectomy was planned to give her a good postoperative quality of life. An intraoperative frozen section was interpreted as malignant neoplasm with a differential diagnosis of lymphoma, small cell carcinoma, and stromal sarcoma.
Gross examination showed tumorous tissues, yellow-white and elastically firm with a gelatinous cut surface, measuring 13 11 6 cm and 4 3 1.5 cm. There were focal myxoid changes. Microscopically, the tissue was composed of monotonous hyperchromatic oval cells with a high nucleus/cytoplasm ratio. No particular Homer-Wright pseudorosettes or neuroectodermal differentiation was identified ( Figure   Figure 2 . The main tumor is yellow-white and elastic with gelatinous content. Some focal myxoid changes are seen. It is fragile, hemorrhagic, and necrotic and arises from the uterus and measures approximately 13 11 cm. It is difficult to resect completely. 3). Immunohistochemically, the tumor cells revealed positive membranous staining for CD99 (O13 antibody) ( Figure 4 ) and some showed weakly positive reactivity for smooth muscle actin. Other immunohistochemical results including leukocyte common antigen, CD20, CD45R0, vimentin, desmin and S100 were all negative. Final pathologic diagnosis was uterine PNET. No malignant cells were found on washing cytology. According to the International Federation of Gynecology and Obstetrics staging system for cancers of the uterine corpus, this patient was diagnosed with at least stage III disease. We could not rule out the tumors invading the bladder mucosa because of microscopic hematuria with 5-7 red blood cells/high-power field, although cystoscopy was not performed preoperatively. Postoperative recovery was uneventful but her family refused any further treatment. At the next outpatient department visit, there was a palpable abdominal mass that grew rapidly and aggressively. The patient was lost to follow-up 1 month after the last examination.
Discussion
The Ewing's family of tumors is composed of Ewing's sarcoma (ES) and pPNETs. The latter term includes different tumors, depending on their location and neural differentiation, such as peripheral neuroepithelioma, Askin tumor, adult neuroblastoma, peripheral neuroblastoma, and PNET. Approximately 83% of cases with ES/PNETs present with the translocation t(11;22)(q24;q12), which can be detected by reverse transcription-polymerase chain reaction [14] . This translocation results in the formation of a chimeric gene, EWS/FLI1 [15] , which may act as an alternative transcriptional factor, potentially promoting oncogenesis or malignant behavior in PNET and ES [16] . However, immunohistochemistry provides a more convenient method to diagnose ES/pPNETs.
Most cases of uterine pPNET present with postmenopausal bleeding, intermenstrual bleeding, an enlarged uterus, or a pelvic mass [17] , but our case presented with acute lower abdominal pain without abnormal vaginal bleeding. Spontaneous tumor rupture is usually the cause of lower abdominal pain. Perimenopausal status may mask abnormal vaginal bleeding. However, there was no vaginal bleeding so we could only suppose that the tumor might not have involved the endometrium.
Mature glial tissue and neuroectoderm in the uterus have been recorded secondary to incomplete therapeutic abortion, or within a uterine teratoma. Benign neoplasms of neuroectodermal origin in the uterus include neurofibroma, ganglioneuroma, and glioma, and these usually arise in the uterine endocervix or endometrium in women who typically present with intermenstrual bleeding [18] . The histogenesis of PNETs of the uterus remains unclear. They may evolve from ectopic neural tissue or may represent differentiation of Mullerian histogenesis [19] . One of three teenagers with uterine pPNET had a history of pregnancy losses that made some believe the tumors arose from implanted neuroectodermal fetal tissue or neuroectodermal migrating cells [1, [20] [21] [22] . However, an implanted neuroectodermal fetal tissue origin seems unlikely because most women with uterine PNETs are postmenopausal. Our patient had had several uterine myomas for years that may have masked the co-existence of uterine PNET. No other mesodermal components or epithelial elements were identified in our patient, precluding the diagnosis of malignant mixed Mullerian tumors (MMMTs). Mullerian derivations (mesodermal), such as endometrial adenocarcinoma and sarcoma, were also suggested by the admixture of PNETs. However, we did not obtain endometrium or uterine myoma using fraction dilatation and curettage or hysterectomy. The question of whether this malignancy arose from uterine myoma and shifted to a neural differentiated tumor remains unknown.
ES and pPNETs are related to malignant small, round-blue cells. The diagnosis is sometimes difficult using routine microscopy because of the nonspecific histologic characteristics. However, membrane reactivity to antibody O13 and identification of translocations facilitate the diagnosis. In 2000, Sinkre et al examined O13 immunoreactivity retrospectively in 40 cases of MMMTs [23] . No O13 immunoreactivity was seen in the malignant epithelium or in sarcomatous components. The glycoprotein p30/32 (CD99) is strongly expressed by ES/PNET (in nearly 90% of cases) and is encoded by the MIC2 gene. CD99 reacts with O13 antibody, but we could not rule out ES/pPNET in our case [23, 24] . However, the presence of glycoprotein p30/32 is nonspecific because it is in several unrelated types of tumors, such as small-cell carcinomas and sex cord-stromal tumors. Nonetheless, it is still a useful tool for the diagnosis of ES/ pPNETs. Most cases present with other nonspecific immunohistochemical markers, including neuronspecific enolase (NSE), vimentin, protein gene product 9.5, glial fibrillary acidic protein, S100, synaptophysin, and Leu 7 [17, 24] . The intensity and amount of tissue reaction for these markers vary from case to case. These tumors have some typical microscopic findings, such as true rosettes with a central lumen, Homer-Wright pseudorosettes, medulloepithelial tubules, glial or ganglion or ganglion-like cells, and perivascular palisading patterns [17, 23] .
In this case, ultrasound showed a heterocomplex irregular pelvic mass, but it seemed like red degeneration of the myoma. Despite other coexistent gynecologic tumors, pPNET of the uterus has the characteristics of easily focal necrosis so it often appears heterocomplex on sonography. The CT imaging characteristics of PNETs, including other locations such as the thoracic, abdominal, and pelvic regions, have not yet been identified. All lesions are large and non-calcified masses with heterogeneous appearance and with variable enhancement with contrast medium on CT due to cystic changes. However, imaging (magnetic resonance imaging and CT) are useful for preoperative evaluation [25] .
The differential diagnosis of PNETs includes other uterine tumors with characteristics of small malignant cells including stromal sarcoma, lymphoma, and smallcell neuroendocrine carcinoma. Endometrial stromal sarcomas are composed of small cells and have a prominent vascular pattern of spiral arteriole-like spaces. Most have estrogen and progesterone receptors but no CD99 immunoreactivity. Lymphoma involving the uterus may also be considered in the differential diagnosis, but its immunohistochemical findings differ from those of PNETs due to its lymphoid markers. Small-cell neuroendocrine carcinomas share most of their immunohistochemical profile with pPNETs, which are positive for chromogranin, synaptophysin, and NSE. However, as for lymphoma and stromal sarcoma, they are also negative for CD99 [5] . Tumors arising from the neural crest (or peripheral nervous system) have also been encountered in the uterine corpus or cervix. These include paraganglioma of typical and melanotic types, pigmented myomatous neurocristoma, ganglioneuroma, and benign and malignant schwannoma [17] . Currently, the definitive diagnosis of PNET is given by positive staining with CD99 and translocation t(11;22)(q24;q12).
To date, there is no standard treatment for pPNETs. Hysterectomy and lymph node dissection followed by radiation and chemotherapy are commonly used. Chemotherapy may have played a role in the patient described by Rose et al, who had metastatic tumors in 10 of 13 pelvic lymph nodes. Postoperatively, this patient was treated with a combination of vincristine, cisplatin, daunorubicin, dactinomycin, cyclophosphamide, and VP-16 and was disease-free for 5.5 years postoperatively [20] . Another patient, reported by Ward et al, received the same regimen and was doing well after 10 years of follow-up [1] .
Though the prognosis of uterine pPNET is poor, we believe that aggressive surgical treatment and adjuvant chemotherapy are warranted. Postoperative radiotherapy could be carried out but its effectiveness remains uncertain.
